Further analysis of the mutation frequency of the CCNB1 gene across various cancer types showed that prostate cancer (4.05%), ovarian epithelial tumor (3.94%), ACC (3.3%), endometrial cancer (3.24%), and bladder cancer (2.19%) had the highest frequencies. This evidence concerns the gene CCNB1 and urinary bladder cancer.